In a murine glioma model where GL261 cells were injected intracranially into the brain of WT or IDO-deficient mice, peripheral expression of IDO had no impact on intratumoral T-cell accumulation or overall survival (60) between the two groups of mice. The gene discussed is IDO1; the disease is central nervous system cancer.